156
Participants
Start Date
May 9, 2016
Primary Completion Date
July 7, 2017
Study Completion Date
July 7, 2017
bupivacaine liposome injectable suspension
10 mL EXPAREL (bupivacaine liposome injectable suspension) expanded with 10 mL normal saline
bupivacaine liposome injectable suspension
20 mL EXPAREL (bupivacaine liposome injectable suspension)
Placebo
20 mL normal saline as single-injection
Ziekenhuis Oost-Limburg, Genk
Aarhus University Hospital, Aarhus
Regionshospital Silkeborg, Silkeborg
Montefiore Medical Center, The Bronx
Indiana Regional Medical Center, Indiana
Chan Soon-Shiong Medical Center, Windber
Thomas Jefferson University Hospital, Philadelphia
Southampton Orthopedics Sports Medicine, Franklin
Duke University Medical Center, Durham
Pensacola Research Associates, Pensacola
Jackson Memorial Hospital/University of Miami, Miami
Horizon Research Group, Inc, Mobile
Fairview Hospital, Cleveland
Plano Surgical Hospital, Plano
Hermann Drive Surgical Hospital, Houston
Westside Surgical Hospital, Houston
Houston Physician's Hospital, Webster
Denver Metro Orthopedics, Englewood
Brigham and Women's Hospital, Boston
Massachusetts General Hospital, Boston
Lead Sponsor
Pacira Pharmaceuticals, Inc
INDUSTRY